Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
36
APNHY Quote, Financials, Valuation and Earnings
Last price:
$9.26
Seasonality move
:
1.79%
Day range:
$9.26 - $9.26
52-week range:
$8.26 - $13.69
Dividend yield:
2.24%
P/E ratio:
15.56x
P/S ratio:
1.72x
P/B ratio:
0.91x
Volume:
--
Avg. volume:
439
1-year change:
-15.63%
Market cap:
$4.1B
Revenue:
$2.4B
EPS (TTM):
$0.53
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
APNHY
Aspen Pharmacare Holdings
|
-- | -- | -- | -- | -- |
|
AIHLF
Adcock Ingram Holdings
|
-- | -- | -- | -- | -- |
|
CCKRF
Clicks Group
|
-- | -- | -- | -- | -- |
|
LTGHY
Life Healthcare Group Holdings
|
-- | -- | -- | -- | -- |
|
MRES
Institute of Biomedical Research
|
-- | -- | -- | -- | -- |
|
NWKHY
Netcare
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
APNHY
Aspen Pharmacare Holdings
|
$9.26 | -- | $4.1B | 15.56x | $0.21 | 2.24% | 1.72x |
|
AIHLF
Adcock Ingram Holdings
|
$2.45 | -- | $359.6M | 8.69x | $0.09 | 6.21% | 0.73x |
|
CCKRF
Clicks Group
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
LTGHY
Life Healthcare Group Holdings
|
$3.50 | -- | $1.3B | 4.99x | $0.07 | 3.16% | 0.92x |
|
MRES
Institute of Biomedical Research
|
$0.0172 | -- | $1.1M | -- | $0.00 | 0% | -- |
|
NWKHY
Netcare
|
$7.80 | -- | $973.5M | 13.17x | $0.16 | 4.5% | 0.74x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
APNHY
Aspen Pharmacare Holdings
|
29.71% | 0.367 | 33.93% | 1.06x |
|
AIHLF
Adcock Ingram Holdings
|
-- | 0.007 | -- | 0.89x |
|
CCKRF
Clicks Group
|
-- | 0.000 | -- | -- |
|
LTGHY
Life Healthcare Group Holdings
|
20.7% | 0.368 | 13.85% | 1.22x |
|
MRES
Institute of Biomedical Research
|
-- | -1.970 | -- | -- |
|
NWKHY
Netcare
|
39.4% | 0.153 | 50.26% | 0.91x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
APNHY
Aspen Pharmacare Holdings
|
-- | -- | 3.7% | 5.16% | -- | -- |
|
AIHLF
Adcock Ingram Holdings
|
-- | -- | 14.87% | 15.05% | -- | -- |
|
CCKRF
Clicks Group
|
-- | -- | -- | -- | -- | -- |
|
LTGHY
Life Healthcare Group Holdings
|
-- | -- | 21.51% | 30.26% | -- | -- |
|
MRES
Institute of Biomedical Research
|
-- | -- | -- | -- | -- | -- |
|
NWKHY
Netcare
|
-- | -- | 8.14% | 13.51% | -- | -- |
Aspen Pharmacare Holdings vs. Competitors
-
Which has Higher Returns APNHY or AIHLF?
Adcock Ingram Holdings has a net margin of -- compared to Aspen Pharmacare Holdings's net margin of --. Aspen Pharmacare Holdings's return on equity of 5.16% beat Adcock Ingram Holdings's return on equity of 15.05%.
Company Gross Margin Earnings Per Share Invested Capital APNHYAspen Pharmacare Holdings-- -- $6.4B AIHLFAdcock Ingram Holdings-- -- $287.4M -
What do Analysts Say About APNHY or AIHLF?
Aspen Pharmacare Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Adcock Ingram Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Aspen Pharmacare Holdings has higher upside potential than Adcock Ingram Holdings, analysts believe Aspen Pharmacare Holdings is more attractive than Adcock Ingram Holdings.
Company Buy Ratings Hold Ratings Sell Ratings APNHYAspen Pharmacare Holdings0 0 0 AIHLFAdcock Ingram Holdings0 0 0 -
Is APNHY or AIHLF More Risky?
Aspen Pharmacare Holdings has a beta of 1.121, which suggesting that the stock is 12.142% more volatile than S&P 500. In comparison Adcock Ingram Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock APNHY or AIHLF?
Aspen Pharmacare Holdings has a quarterly dividend of $0.21 per share corresponding to a yield of 2.24%. Adcock Ingram Holdings offers a yield of 6.21% to investors and pays a quarterly dividend of $0.09 per share. Aspen Pharmacare Holdings pays 34.63% of its earnings as a dividend. Adcock Ingram Holdings pays out -- of its earnings as a dividend. Aspen Pharmacare Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios APNHY or AIHLF?
Aspen Pharmacare Holdings quarterly revenues are --, which are smaller than Adcock Ingram Holdings quarterly revenues of --. Aspen Pharmacare Holdings's net income of -- is lower than Adcock Ingram Holdings's net income of --. Notably, Aspen Pharmacare Holdings's price-to-earnings ratio is 15.56x while Adcock Ingram Holdings's PE ratio is 8.69x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aspen Pharmacare Holdings is 1.72x versus 0.73x for Adcock Ingram Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APNHYAspen Pharmacare Holdings1.72x 15.56x -- -- AIHLFAdcock Ingram Holdings0.73x 8.69x -- --
-
Which has Higher Returns APNHY or CCKRF?
Clicks Group has a net margin of -- compared to Aspen Pharmacare Holdings's net margin of --. Aspen Pharmacare Holdings's return on equity of 5.16% beat Clicks Group's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital APNHYAspen Pharmacare Holdings-- -- $6.4B CCKRFClicks Group-- -- -- -
What do Analysts Say About APNHY or CCKRF?
Aspen Pharmacare Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Clicks Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Aspen Pharmacare Holdings has higher upside potential than Clicks Group, analysts believe Aspen Pharmacare Holdings is more attractive than Clicks Group.
Company Buy Ratings Hold Ratings Sell Ratings APNHYAspen Pharmacare Holdings0 0 0 CCKRFClicks Group0 0 0 -
Is APNHY or CCKRF More Risky?
Aspen Pharmacare Holdings has a beta of 1.121, which suggesting that the stock is 12.142% more volatile than S&P 500. In comparison Clicks Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock APNHY or CCKRF?
Aspen Pharmacare Holdings has a quarterly dividend of $0.21 per share corresponding to a yield of 2.24%. Clicks Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aspen Pharmacare Holdings pays 34.63% of its earnings as a dividend. Clicks Group pays out -- of its earnings as a dividend. Aspen Pharmacare Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios APNHY or CCKRF?
Aspen Pharmacare Holdings quarterly revenues are --, which are smaller than Clicks Group quarterly revenues of --. Aspen Pharmacare Holdings's net income of -- is lower than Clicks Group's net income of --. Notably, Aspen Pharmacare Holdings's price-to-earnings ratio is 15.56x while Clicks Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aspen Pharmacare Holdings is 1.72x versus -- for Clicks Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APNHYAspen Pharmacare Holdings1.72x 15.56x -- -- CCKRFClicks Group-- -- -- --
-
Which has Higher Returns APNHY or LTGHY?
Life Healthcare Group Holdings has a net margin of -- compared to Aspen Pharmacare Holdings's net margin of --. Aspen Pharmacare Holdings's return on equity of 5.16% beat Life Healthcare Group Holdings's return on equity of 30.26%.
Company Gross Margin Earnings Per Share Invested Capital APNHYAspen Pharmacare Holdings-- -- $6.4B LTGHYLife Healthcare Group Holdings-- -- $980.6M -
What do Analysts Say About APNHY or LTGHY?
Aspen Pharmacare Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Life Healthcare Group Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Aspen Pharmacare Holdings has higher upside potential than Life Healthcare Group Holdings, analysts believe Aspen Pharmacare Holdings is more attractive than Life Healthcare Group Holdings.
Company Buy Ratings Hold Ratings Sell Ratings APNHYAspen Pharmacare Holdings0 0 0 LTGHYLife Healthcare Group Holdings0 0 0 -
Is APNHY or LTGHY More Risky?
Aspen Pharmacare Holdings has a beta of 1.121, which suggesting that the stock is 12.142% more volatile than S&P 500. In comparison Life Healthcare Group Holdings has a beta of 0.804, suggesting its less volatile than the S&P 500 by 19.635%.
-
Which is a Better Dividend Stock APNHY or LTGHY?
Aspen Pharmacare Holdings has a quarterly dividend of $0.21 per share corresponding to a yield of 2.24%. Life Healthcare Group Holdings offers a yield of 3.16% to investors and pays a quarterly dividend of $0.07 per share. Aspen Pharmacare Holdings pays 34.63% of its earnings as a dividend. Life Healthcare Group Holdings pays out 196.23% of its earnings as a dividend. Aspen Pharmacare Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Life Healthcare Group Holdings's is not.
-
Which has Better Financial Ratios APNHY or LTGHY?
Aspen Pharmacare Holdings quarterly revenues are --, which are smaller than Life Healthcare Group Holdings quarterly revenues of --. Aspen Pharmacare Holdings's net income of -- is lower than Life Healthcare Group Holdings's net income of --. Notably, Aspen Pharmacare Holdings's price-to-earnings ratio is 15.56x while Life Healthcare Group Holdings's PE ratio is 4.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aspen Pharmacare Holdings is 1.72x versus 0.92x for Life Healthcare Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APNHYAspen Pharmacare Holdings1.72x 15.56x -- -- LTGHYLife Healthcare Group Holdings0.92x 4.99x -- --
-
Which has Higher Returns APNHY or MRES?
Institute of Biomedical Research has a net margin of -- compared to Aspen Pharmacare Holdings's net margin of --. Aspen Pharmacare Holdings's return on equity of 5.16% beat Institute of Biomedical Research's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital APNHYAspen Pharmacare Holdings-- -- $6.4B MRESInstitute of Biomedical Research-- -- -- -
What do Analysts Say About APNHY or MRES?
Aspen Pharmacare Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Institute of Biomedical Research has an analysts' consensus of -- which suggests that it could fall by --. Given that Aspen Pharmacare Holdings has higher upside potential than Institute of Biomedical Research, analysts believe Aspen Pharmacare Holdings is more attractive than Institute of Biomedical Research.
Company Buy Ratings Hold Ratings Sell Ratings APNHYAspen Pharmacare Holdings0 0 0 MRESInstitute of Biomedical Research0 0 0 -
Is APNHY or MRES More Risky?
Aspen Pharmacare Holdings has a beta of 1.121, which suggesting that the stock is 12.142% more volatile than S&P 500. In comparison Institute of Biomedical Research has a beta of 2.581, suggesting its more volatile than the S&P 500 by 158.057%.
-
Which is a Better Dividend Stock APNHY or MRES?
Aspen Pharmacare Holdings has a quarterly dividend of $0.21 per share corresponding to a yield of 2.24%. Institute of Biomedical Research offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aspen Pharmacare Holdings pays 34.63% of its earnings as a dividend. Institute of Biomedical Research pays out -- of its earnings as a dividend. Aspen Pharmacare Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios APNHY or MRES?
Aspen Pharmacare Holdings quarterly revenues are --, which are smaller than Institute of Biomedical Research quarterly revenues of --. Aspen Pharmacare Holdings's net income of -- is lower than Institute of Biomedical Research's net income of --. Notably, Aspen Pharmacare Holdings's price-to-earnings ratio is 15.56x while Institute of Biomedical Research's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aspen Pharmacare Holdings is 1.72x versus -- for Institute of Biomedical Research. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APNHYAspen Pharmacare Holdings1.72x 15.56x -- -- MRESInstitute of Biomedical Research-- -- -- --
-
Which has Higher Returns APNHY or NWKHY?
Netcare has a net margin of -- compared to Aspen Pharmacare Holdings's net margin of --. Aspen Pharmacare Holdings's return on equity of 5.16% beat Netcare's return on equity of 13.51%.
Company Gross Margin Earnings Per Share Invested Capital APNHYAspen Pharmacare Holdings-- -- $6.4B NWKHYNetcare-- -- $1.1B -
What do Analysts Say About APNHY or NWKHY?
Aspen Pharmacare Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Netcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Aspen Pharmacare Holdings has higher upside potential than Netcare, analysts believe Aspen Pharmacare Holdings is more attractive than Netcare.
Company Buy Ratings Hold Ratings Sell Ratings APNHYAspen Pharmacare Holdings0 0 0 NWKHYNetcare0 0 0 -
Is APNHY or NWKHY More Risky?
Aspen Pharmacare Holdings has a beta of 1.121, which suggesting that the stock is 12.142% more volatile than S&P 500. In comparison Netcare has a beta of 0.083, suggesting its less volatile than the S&P 500 by 91.675%.
-
Which is a Better Dividend Stock APNHY or NWKHY?
Aspen Pharmacare Holdings has a quarterly dividend of $0.21 per share corresponding to a yield of 2.24%. Netcare offers a yield of 4.5% to investors and pays a quarterly dividend of $0.16 per share. Aspen Pharmacare Holdings pays 34.63% of its earnings as a dividend. Netcare pays out -- of its earnings as a dividend. Aspen Pharmacare Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios APNHY or NWKHY?
Aspen Pharmacare Holdings quarterly revenues are --, which are smaller than Netcare quarterly revenues of --. Aspen Pharmacare Holdings's net income of -- is lower than Netcare's net income of --. Notably, Aspen Pharmacare Holdings's price-to-earnings ratio is 15.56x while Netcare's PE ratio is 13.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aspen Pharmacare Holdings is 1.72x versus 0.74x for Netcare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APNHYAspen Pharmacare Holdings1.72x 15.56x -- -- NWKHYNetcare0.74x 13.17x -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is up 22.25% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 20.59% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 19.13% over the past day.
